Reckitt Benckiser Group PLC Total Liabilities
Reckitt Benckiser Group PLC total liabilities. Based on the latest financial reports, Reckitt Benckiser Group PLC (RKT) has total liabilities worth GBX18.72 Billion GBX (≈ $2.28 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of Reckitt Benckiser Group PLC to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Reckitt Benckiser Group PLC (2000–2025)
Total liabilities of Reckitt Benckiser Group PLC from 2000 to 2025. This chart illustrates how Reckitt Benckiser Group PLC's total liabilities have evolved over time, based on quarterly financial data. Check RKT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Reckitt Benckiser Group PLC Competitors by Total Liabilities
The table below lists competitors of Reckitt Benckiser Group PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Jinsheng New Materials Co
SHE:300849
|
China | CN¥191.82 Million |
|
Stenhus Fastigheter I Norden AB
ST:SFAST
|
Sweden | Skr8.96 Billion |
|
Enity
ST:ENITY
|
Sweden | Skr35.75 Billion |
|
Israel Land Development Company Co Ltd
TA:ILDC
|
Israel | ILA7.45 Billion |
|
Suzhou Kelida Bldg &
SHG:603828
|
China | CN¥3.37 Billion |
|
Hubei Fuxing Science and Technology Co Ltd
SHE:000926
|
China | CN¥15.58 Billion |
|
Astral Foods Ltd.
JSE:ARL
|
South Africa | ZAC3.92 Billion |
|
Frontera Energy Corp
TO:FEC
|
Canada | CA$1.29 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Reckitt Benckiser Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see RKT asset base.
Liquidity & Leverage Metrics
Reckitt Benckiser Group PLC Total Liabilities Ratios Explained
Reckitt Benckiser Group PLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Reckitt Benckiser Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Reckitt Benckiser Group PLC (2000–2025)
The table below shows the annual total liabilities of Reckitt Benckiser Group PLC from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | GBX17.29 Billion ≈ $2.10 Million |
-6.95% |
| 2024-12-31 | GBX18.58 Billion ≈ $2.26 Million |
-0.48% |
| 2023-12-31 | GBX18.67 Billion ≈ $2.27 Million |
-3.07% |
| 2022-12-31 | GBX19.26 Billion ≈ $2.34 Million |
-1.20% |
| 2021-12-31 | GBX19.49 Billion ≈ $2.37 Million |
-11.93% |
| 2020-12-31 | GBX22.13 Billion ≈ $2.69 Million |
-2.64% |
| 2019-12-31 | GBX22.73 Billion ≈ $2.77 Million |
-0.56% |
| 2018-12-31 | GBX22.86 Billion ≈ $2.78 Million |
-2.47% |
| 2017-12-31 | GBX23.44 Billion ≈ $2.85 Million |
+144.34% |
| 2016-12-31 | GBX9.59 Billion ≈ $1.17 Million |
+14.72% |
| 2015-12-31 | GBX8.36 Billion ≈ $1.02 Million |
-3.46% |
| 2014-12-31 | GBX8.66 Billion ≈ $1.05 Million |
-1.71% |
| 2013-12-31 | GBX8.81 Billion ≈ $1.07 Million |
-3.77% |
| 2012-12-31 | GBX9.16 Billion ≈ $1.11 Million |
+9.74% |
| 2011-12-31 | GBX8.35 Billion ≈ $1.02 Million |
+0.64% |
| 2010-12-31 | GBX8.29 Billion ≈ $1.01 Million |
+78.44% |
| 2009-12-31 | GBX4.65 Billion ≈ $565.41K |
-21.08% |
| 2008-12-31 | GBX5.89 Billion ≈ $716.40K |
+69.05% |
| 2007-12-31 | GBX3.48 Billion ≈ $423.78K |
-10.02% |
| 2006-12-31 | GBX3.87 Billion ≈ $470.99K |
+64.23% |
| 2005-12-31 | GBX2.36 Billion ≈ $286.78K |
+3.74% |
| 2004-12-31 | GBX2.27 Billion ≈ $276.44K |
-3.15% |
| 2003-12-31 | GBX2.35 Billion ≈ $285.44K |
+1.82% |
| 2002-12-31 | GBX2.30 Billion ≈ $280.33K |
+5.83% |
| 2001-12-31 | GBX2.18 Billion ≈ $264.88K |
-0.55% |
| 2000-12-31 | GBX2.19 Billion ≈ $266.34K |
-- |
About Reckitt Benckiser Group PLC
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil a… Read more